Icon PLC
ICLR: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|#@ | LOCK|&b | LOCK|M^XHM@$ |
Narrow-Moat Icon Faces Elevated Uncertainty Amid Ongoing Accounting Review and Macroeconomic Issues
Business Strategy and Outlook
Icon has the capabilities and expertise to execute late-stage contract research effectively, including global reach, full-service offerings, extensive regulatory and clinical knowledge, and investment in innovation and technology. Icon is one of a handful of contract research organizations with the global infrastructure to carry out these late-stage, multinational clinical trials.
